Use of 2- (2-nitro-4-trifluorometilbenzoil) -1,3-ciclohexanodiona in the treatment of parkinson's disease.

The use of 2- (2-nitro-4-trifluoromethylbenzoyl) -1,3-cyclohexanedione (compound 2), or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in the treatment of a neurodegenerative disease.